Literature DB >> 29935486

Comparison of intravenous ibuprofen and acetaminophen for postoperative multimodal pain management in bariatric surgery: A randomized controlled trial.

Gulay Erdogan Kayhan1, Mukadder Sanli2, Ulku Ozgul3, Ramazan Kirteke2, Saim Yologlu4.   

Abstract

STUDY
OBJECTIVE: Multimodal analgesic strategies are recommended to decrease opioid requirements and opioid-induced respiratory complications in patients undergoing laparoscopic bariatric surgery. Recent studies have demonstrated that intravenous ibuprofen decreases opioid consumption compared with placebo. The primary aim of this study was to compare the effect of intravenous ibuprofen and intravenous acetaminophen on opioid consumption. We also aimed to compare postoperative pain levels and side effects of the drugs.
DESIGN: Randomized, double-blinded study.
SETTING: University hospital. PATIENTS: Eighty patients, aged 18-65 years, (ASA physical status II-III) undergoing laparoscopic sleeve gastrectomy or laparoscopic Roux-en-Y gastric bypass surgery were included in this study.
INTERVENTIONS: Patients were randomized to receive 800 mg ibuprofen or 1 g acetaminophen intravenously every 6 h for the first 24 h following surgery; in addition, patient-controlled analgesia with morphine was administered. MEASUREMENTS: Postoperative morphine consumption in the first 24 h, visual analog scale (VAS) pain scores at rest and with movement, and opioid related side effects were assessed. In addition, time to passage of flatus, surgical complications, lengths of intensive care unit and hospital stay, and laboratory parameters were recorded. MAIN
RESULTS: The mean morphine consumption was 23.94 ± 13.89 mg in iv ibuprofen group and 30.23 ± 13.76 mg in the acetaminophen group [mean difference: -6.28 (95% CI, -12.70, 0.12); P = 0.055]. The use of intravenous ibuprofen was associated with reduction in pain at rest (AUC, 1- to 24-h, P < 0.001 and 12- to 24-h, P = 0.021) and pain with movement (AUC, 1-24, 6-24, and 12-24 h, P < 0.001). Intravenous ibuprofen was well tolerated with no serious side effects except dizziness.
CONCLUSIONS: Intravenous ibuprofen did not significantly reduce opioid consumption compared to intravenous acetaminophen; however, it reduced the severity of pain. Intravenous ibuprofen may be a good alternative to intravenous acetaminophen as part of a multimodal postoperative analgesia in patients undergoing bariatric surgery.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Acetaminophen; Bariatric surgery; Ibuprofen intravenous solution; Pain, postoperative

Mesh:

Substances:

Year:  2018        PMID: 29935486     DOI: 10.1016/j.jclinane.2018.06.030

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  5 in total

Review 1.  Single-dose intravenous ibuprofen for acute postoperative pain in adults.

Authors:  McKenzie C Ferguson; Roman Schumann; Sean Gallagher; Ewan D McNicol
Journal:  Cochrane Database Syst Rev       Date:  2021-09-09

Review 2.  Ketamine as a component of multimodal analgesia for pain management in bariatric surgery: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Mohamed Ali Mohamed Ali Chaouch; Mohamed Aziz Daghmouri; Marie-Christine Boutron; Jean-Marc Ferraz; Sofia Usai; Olivier Soubrane; Marc Beaussier; Guillaume Pourcher; Hani Oweira
Journal:  Ann Med Surg (Lond)       Date:  2022-05-14

3.  Efficacy of acetaminophen versus ibuprofen for the management of rotator cuff-related shoulder pain: Randomized open-label study.

Authors:  Yazed AlRuthia; Sultan Alghadeer; Bander Balkhi; Haya M Almalag; Hana Alsobayel; Faris Alodaibi; Fakhr Alayoubi; Amal S Alkhamali; Samar Alshuwairikh; Futoun N Alqahtani; Hisham Alsanawi
Journal:  Saudi Pharm J       Date:  2019-06-10       Impact factor: 4.330

Review 4.  A Meta-Analysis of the Analgesic Efficacy of Single-Doses of Ibuprofen Compared to Traditional Non-Opioid Analgesics Following Third Molar Surgery.

Authors:  Lorenzo Franco-de la Torre; Norma Patricia Figueroa-Fernández; Diana Laura Franco-González; Ángel Josabad Alonso-Castro; Federico Rivera-Luna; Mario Alberto Isiordia-Espinoza
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-14

Review 5.  Misalignment of Stakeholder Incentives in the Opioid Crisis.

Authors:  Alireza Boloori; Bengt B Arnetz; Frederi Viens; Taps Maiti; Judith E Arnetz
Journal:  Int J Environ Res Public Health       Date:  2020-10-16       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.